| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/18/2004 | EP1446152A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors |
| 08/18/2004 | EP1446150A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 08/18/2004 | EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0833920B1 Transferrin receptor genes |
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522516A Secure header information for multi-content e-mail |
| 08/18/2004 | CN1522156A Novel engineered superantigen for human therapy |
| 08/18/2004 | CN1522155A Method for producing a vaccine |
| 08/18/2004 | CN1522154A Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 08/18/2004 | CN1522153A Novel composition |
| 08/18/2004 | CN1522152A Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| 08/18/2004 | CN1521184A Hepatitis B virus pre-S mutain, and its preparing process and application |
| 08/18/2004 | CN1520886A Application of mycoplasma-resistant pharmaceutical and P37 protein blocking agent in preparing antineoplastic medicine |
| 08/18/2004 | CN1520884A Immunological regulator and application thereof |
| 08/18/2004 | CN1520883A O, A type bivalent inactivated vaccine for foot-and-mouth disease of ruminant as cattle and sheep |
| 08/18/2004 | CN1162547C Hepatitis B virus antisense RNA expression vector targeting liver cancer and its construction process and use |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/18/2004 | CN1162182C Method of protein production using chondriosome translation system |
| 08/18/2004 | CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium |
| 08/17/2004 | US6777546 Expression vector for use in the treatment of defects of immunological response |
| 08/17/2004 | US6777247 Nervous necrosis virus protein |
| 08/17/2004 | US6777220 Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
| 08/17/2004 | US6777203 Telomerase promoter driving expression of therapeutic gene sequences |
| 08/17/2004 | US6777202 Process for the recombinant production of s-layer proteins in gram-negative host cells |
| 08/17/2004 | US6777194 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 08/17/2004 | US6777192 Contacting the sample with an isolated recombinant immunodominant neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex |
| 08/17/2004 | US6777191 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in diagnosis of viral infection |
| 08/17/2004 | US6776993 Tuberculosis vaccine |
| 08/17/2004 | US6776992 Methods for treating tension headache |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/17/2004 | CA2097702C Dermatomycosis vaccine |
| 08/12/2004 | WO2004067747A1 Recombinant hepatitis a virus antigens obtained in plant cells |
| 08/12/2004 | WO2004067743A1 Vaccine production using transposon based vectors |
| 08/12/2004 | WO2004067718A2 Necrosis-deficient mutants of tuberculosis bacteria |
| 08/12/2004 | WO2004067707A2 Administration of transposon-based vectors to reproductive organs |
| 08/12/2004 | WO2004067706A2 Production of multimeric proteins |
| 08/12/2004 | WO2004067698A2 Helminth-derived antigens having capacity of providing protection against parasites |
| 08/12/2004 | WO2004067564A2 Compositions against cancer antigen liv-1 and uses thereof |
| 08/12/2004 | WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | WO2004067553A2 Tolerance-induced targeted antibody production |
| 08/12/2004 | WO2004067038A1 Anthracycline-antibody conjugates |
| 08/12/2004 | WO2004067034A1 Use of anti-cd100 antibodies |
| 08/12/2004 | WO2004067033A1 Mucosal meningococcal vaccines |
| 08/12/2004 | WO2004067032A2 Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes |
| 08/12/2004 | WO2004067031A1 Canine vaccines against bordetella bronchiseptica |
| 08/12/2004 | WO2004067029A1 Method of preparing a vaccine and anti-tumor vaccines |
| 08/12/2004 | WO2004067020A1 Dna vaccine composition with enhanced immunogenicity |
| 08/12/2004 | WO2004066961A2 Use of sendai virus as a human parainfluenza vaccine |
| 08/12/2004 | WO2004066957A2 ANTI-INTEGRIN ανβ3 ANTIBODY FORMULATIONS AND USES THEREOF |
| 08/12/2004 | WO2004066946A2 Method for evaluating the efficacy of certain cancer treatments |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004066932A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066931A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066928A2 Use of mycobacterial vaccines in cd4+ or cd8+ lymphocyte-deficient mammals |
| 08/12/2004 | WO2004066828A2 Apparatus for endoscopic surgical procedures |
| 08/12/2004 | WO2004052392A3 Cancer immunotherapy using polycomb proteins |
| 08/12/2004 | WO2004045559A3 Method for the prevention of malaria |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004041182A3 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 08/12/2004 | WO2004032880A3 Method for inhibiting angiogenesis with ship-1 inhibitors |
| 08/12/2004 | WO2004032860A3 Hiv vaccine formulations |
| 08/12/2004 | WO2004026250A3 Re-activated t-cells for adoptive immunotherapy |
| 08/12/2004 | WO2004021994A3 Cancer therapy using whole glucan particles and antibodies |
| 08/12/2004 | WO2004020592A3 Retroductal salivary gland genetic vaccination |
| 08/12/2004 | WO2004020585A3 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 08/12/2004 | WO2004016222A3 Hepatitis c viral-like particle purification |
| 08/12/2004 | WO2004015071A3 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 08/12/2004 | WO2004011611A3 Taci antibodies and uses thereof |
| 08/12/2004 | WO2004007531A3 Activated checkpoint therapy and methods of use thereof |
| 08/12/2004 | WO2004006857A3 Glanders/meliodosis vaccines |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003048337A3 Antibody to latent membrane proteins and uses thereof |
| 08/12/2004 | WO2003037060A3 Compositions and methods for wt1 specific immunotherapy |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | US20040158053 Plasmid comprising nucleotide sequences coding antigenic proteins for use in prevention and treatment of infectious and neoplastic diseases; gene therapy |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040157791 Systemic immune activation method using nucleic acid-lipid complexes |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157779 Prevention and treatment of amyloidogenic disease |
| 08/12/2004 | US20040157311 isolatable from turkeys in the field; makes these viruses particularly suited for preparing a live vaccine for protecting poultry against disease conditions resulting from infection |
| 08/12/2004 | US20040157310 Methods for enhancing the production of viral vaccines in cell culture |
| 08/12/2004 | US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits |
| 08/12/2004 | US20040157299 by transducing the tumor cells with a herpes simplex virus amplicon containing the gene for an immunomodulating protein; for multi-transduced cells for multi-targeted therapy; genetic engineering |
| 08/12/2004 | US20040157296 Canine and feline B7-2 proteins, compositions and uses thereof |
| 08/12/2004 | US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157241 Haemophilus adherence and penetration proteins |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157212 to suitable titer on Vero cells, without prior adaptation; shows reactivity in an immuno-fluorescence-technique (IFT) with a polyclonal antiserum raised against a reovirus; for vaccines |
| 08/12/2004 | US20040156913 poly(alpha-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, formed using detergents; biologically active macromolecule adsorbed on surface |
| 08/12/2004 | US20040156868 Chicken anaemia viruses of low pathogenicity |
| 08/12/2004 | US20040156867 Proteosome influenza vaccine |